UNSPSC 51283703: Cefbuperazone

This classification denotes a cephalosporin antibiotic with the molecular formula C22H29N9O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0785J3X40, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)-3-hydroxy-1-oxobutyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha,7(2r*,3s*)))- but generally known as cefbuperazone, which bears US NIH Compound Identifier 53522.

UNSPSC 51283703 Cefbuperazone is a Commodity code that in recent state and local activity functions as a catch-all taxonomy marker for diverse pharmaceutical and medical supply procurement, though the code's nominal scope (a specific antibiotic agent) does not align with the work actually being solicited. State and local governments are buying naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products for health systems and employee health plans, and direct-to-manufacturer prescription fulfillment services. Issuing bodies span county health departments, city fire rescue operations, state health and human services commissions, and cooperative purchasing alliances serving multi-state jurisdictions. The scope mismatch suggests this code may be applied inconsistently across procurement systems or functions as a default pharmaceutical-family marker when more specific commodity codes are unavailable.

Recent activity shows solicitations from Seminole County, Florida (IFB for naloxone and drug deactivation systems, due July 26, 2023), the City of Tampa (ITB for medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract amount of $700,000.00 and a small local business enterprise set-aside), the Texas Health and Human Services Commission (RFI for direct-to-manufacturer prescription program vendor capabilities, due April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance (RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson). Geographic activity spans Florida, Texas, Minnesota, and Oregon. The code shows scattered recent municipal, county, and state-level procurement across health departments and emergency response divisions, though the nominal code definition bears little relevance to actual solicitation scope.